chr12-2922327-G-A
Variant summary
Our verdict is Likely benign. Variant got -3 ACMG points: 2P and 5B. PM2BP4_StrongBS1_Supporting
The NM_003324.5(TULP3):c.319G>A(p.Val107Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000153 in 1,614,154 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_003324.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -3 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TULP3 | NM_003324.5 | c.319G>A | p.Val107Ile | missense_variant | 4/11 | ENST00000448120.7 | NP_003315.2 | |
TULP3 | NM_001160408.2 | c.319G>A | p.Val107Ile | missense_variant | 4/12 | NP_001153880.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TULP3 | ENST00000448120.7 | c.319G>A | p.Val107Ile | missense_variant | 4/11 | 2 | NM_003324.5 | ENSP00000410051.2 |
Frequencies
GnomAD3 genomes AF: 0.000913 AC: 139AN: 152176Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000262 AC: 66AN: 251434Hom.: 0 AF XY: 0.000191 AC XY: 26AN XY: 135886
GnomAD4 exome AF: 0.0000739 AC: 108AN: 1461860Hom.: 1 Cov.: 31 AF XY: 0.0000550 AC XY: 40AN XY: 727232
GnomAD4 genome AF: 0.000913 AC: 139AN: 152294Hom.: 0 Cov.: 32 AF XY: 0.000900 AC XY: 67AN XY: 74466
ClinVar
Submissions by phenotype
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Nov 06, 2023 | The c.319G>A (p.V107I) alteration is located in exon 4 (coding exon 4) of the TULP3 gene. This alteration results from a G to A substitution at nucleotide position 319, causing the valine (V) at amino acid position 107 to be replaced by an isoleucine (I). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at